The effect of flurbiprofen (2-(2-fluoro-4-biphenylyl) propionic acid) on platelet function and blood coagulation.
D000244:Adenosine Diphosphate / Q000037:antagonists & inhibitors; D000284:Administration, Oral; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000097:blood / Q000494:pharmacology*; D001713:Biphenyl Compounds / Q000494:pharmacology*; D001772:Blood Cell Count; D001777:Blood Coagulation / Q000187:drug effects*; D001780:Blood Coagulation Tests; D002250:Carbon Radioisotopes; D003094:Collagen / Q000037:antagonists & inhibitors; D004837:Epinephrine / Q000037:antagonists & inhibitors; D005461:Fluorine / Q000494:pharmacology; D006801:Humans; D008297:Male; D010973:Platelet Adhesiveness / Q000187:drug effects*; D010974:Platelet Aggregation / Q000187:drug effects*; D011422:Propionates / Q000494:pharmacology*; D011517:Prothrombin Time; D012702:Serotonin Antagonists; D013917:Thrombin / Q000037:antagonists & inhibitors; D013923:Thromboembolism / Q000188:drug therapy
D000893:Anti-Inflammatory Agents; D001713:Biphenyl Compounds; D002250:Carbon Radioisotopes; D011422:Propionates; D012702:Serotonin Antagonists; D005461:Fluorine; D000244:Adenosine Diphosphate; D003094:Collagen; D013917:Thrombin; D004837:Epinephrine